ATRICURE INC (ATRC)
Health Care · Cardiac ablation and surgical arrhythmia management devices · NASDAQ
AtriCure is a leading surgical device company treating atrial fibrillation and post-operative pain through minimally invasive cardiac ablation and cryotherapy technologies.
What ATRICURE INC does
AtriCure develops and markets surgical treatments and therapies for atrial fibrillation (AFib), left atrial appendage (LAA) management, and post-operative pain management. The company sells cardiac ablation and LAA management products used by physicians during open-heart and minimally invasive surgical procedures, as well as cryotherapy probes for nerve freezing during cardiac, thoracic, and amputation surgeries. Products are sold directly in the US and select international markets, and through distributors in other regions.
Themes: ["Atrial fibrillation (AFib) ablation","Left atrial appendage (LAA) management","Surgical pain management / cryotherapy","Minimally invasive cardiac surgery","Cardiac arrhythmia treatment"]
Fundamentals
- Price$34.56 as of 2026-07-09 close
- Market cap$1.7B as of 2026-07-10
- 1-year return+8.3% as of 2026-07-09 close
- Net margin-0.8% as of 2026-07-10
- Gross margin+75.6% as of 2026-07-10
- ROE-0.9% as of 2026-07-10
- Debt / equity0.14 as of 2026-07-10
- Revenue growth (YoY)+15.0% as of 2026-07-10
- Revenue CAGR (3y)+17.4% SEC XBRL
- Beta1.26 as of 2026-07-10
Key risks (from latest filing)
["Dependence on adoption of surgical ablation procedures for AFib, which competes with catheter-based and pharmaceutical alternatives; changes in clinical guidelines or physician preferences could reduce demand","Reliance on direct sales force in key markets (US, Western Europe, Australia, Canada) and distributor networks internationally; sales execution and reimbursement challenges could impact growth","Regulatory and reimbursement risks; changes in coverage policies or approval requirements for cardiac and pain management devices could limit market access"]
Competitors & peers
- Johnson & Johnson (J&J) - cardiac ablation and electrophysiology
- Abbott Laboratories (ABT) - AFib management and electrophysiology devices
- Boston Scientific (BSX) - cardiac ablation and LAA closure devices
- Medtronic (MDT) - surgical ablation and cardiac rhythm management
- Baylis Medical - radiofrequency ablation systems
- CryoLife (CRYO) - surgical bioimplants and pain management
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.